New Horizon Aircraft Announces Closing of $2.9 Million Public Offering
TORONTO, Aug. 21, 2024 (GLOBE NEWSWIRE) — New Horizon Aircraft (NASDAQ: HOVR), today closed its previously announced underwritten public offering […]
Inari Medical to Present at Upcoming Investor Conferences
IRVINE, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a […]
Clover Health to Participate in Upcoming 2024 Wells Fargo Healthcare Conference
FRANKLIN, Tenn., Aug. 21, 2024 (GLOBE NEWSWIRE) — Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), […]
Woodward to Participate in Fireside Chat Hosted by Goldman Sachs
FORT COLLINS, Colo., Aug. 21, 2024 (GLOBE NEWSWIRE) — Woodward (NASDAQ: WWD) today announced that Chip Blankenship, Chairman and Chief Executive […]
Breeze Holdings Acquisition Corp. Provides Update on Trading Status and Potential Business Combination
IRVING, Texas, Aug. 21, 2024 (GLOBE NEWSWIRE) — Breeze Holdings Acquisition Corp. (OTCQX: BRZH) (“Breeze” or the “Company”), has been […]
Spa Monarch jumps two spots to #2 best spa in the nation, as voted on by USA Today readers
Denver, CO, Aug. 21, 2024 (GLOBE NEWSWIRE) — Monarch Casino Resort Spa is excited to announce that after four weeks […]
Clover Leaf Capital Corp. Announces Postponement of Special Meeting of Stockholders Date to August 27, 2024
MIAMI, FL and KANSAS CITY, KS, Aug. 21, 2024 (GLOBE NEWSWIRE) — Clover Leaf Capital Corp. (Nasdaq: CLOE) (“CLOE” or […]
Amid falling confidence, 1 in 3 U.S. employees wants to phase into retirement
NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) — While millions of older working Americans are delaying plans to retire amid […]
Latham Takes the Plunge With L.C. Williams & Associates
LATHAM, N.Y., Aug. 21, 2024 (GLOBE NEWSWIRE) — Signaling a new era of investment in its business, brand and channel […]
Kymera Therapeutics Announces Closing of Upsized $225 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
WATERTOWN, Mass., Aug. 21, 2024 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new […]
